Skip to content
Pompe Disease News logo
  • About Pompe
    What is Pompe disease?
    Types
    Symptoms
    Causes
    Diagnosis
    Treatment options
    • Lumizyme
    • Nexviazyme
    • Pombiliti + Opfolda
  • News
  • Columns
    The Pompe Community Diaries – Anthony Wu
    Powering Through Pompe — Keara Engle
    Archived columns
    • On the Road to Pompe — Dwayne Wilson
  • Living with Pompe
    Adaptive clothing
    Living with Pompe disease
    ERT and enzyme stabilizers
    The ERT process
    Your daily routine with LOPD
    Adaptive equipment
    Late-onset Pompe disease
    Dwayne’s story
    Expert voice: Safe and effective exercise
    How is Pompe disease inherited?
    Pompe disease and diet
    Reproductive options
    Support groups and resources
    LOPD and respiratory health
    Mental health
    Pompe and fatigue
    Travel and LOPD
    Exercise and physical therapy
    Science behind treatment
    ERT challenges
    Navigating school and work
    Pompe prevalence
    Pompe disease progression
  • Pompe pathways
    ERT home infusions
    Therapeutic crossroads
    Tips for caregivers
    Maximizing doctor’s appointments
    Building an LOPD care team
    Financial planning with Pompe
    Work and Pompe
    Occupational therapy
    Pompe and pain
  • FAQs
  • Advocacy partners
  • What can we help you find today?

May 26, 2020 Health Insights by Mary Chapman

What Is Genetic Counseling and Why Is It Important in Pompe Disease?

If you, your partner, or anyone else in the family has Pompe disease, you may wonder whether the disorder also will affect your future children. Genetic counseling can help you calculate the risk and help you with genetic testing and family planning. What do genetic counselors do? Genetic…

January 31, 2019 News by Mary Chapman

FDA Revising ‘Draft Guidance’ on Developing Treatments for Rare Diseases

The U.S. Food and Drug Administration(FDA) is updating its 2015 draft guidelines for drug discovery in rare diseases, with new guidance on natural history— how disorders such as spinal muscle atrophy(SMA) run their course if untreated — the choice of “efficacy endpoints” in clinical trials, and how…

Recent Posts

  • Gene, enzyme replacement improve mice’s breathing, limb strength
  • Short-distance walking speed test in Pompe disease is less demanding
  • Nervous system involvement is common in Pompe disease: Study


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.